G. Fabbri and R. Dalla-favera, The molecular pathogenesis of chronic lymphocytic leukaemia, Nat Rev Cancer, vol.16, pp.145-162, 2016.

R. Jitschin, M. Braun, M. Buttner, K. Dettmer-wilde, J. Bricks et al.,

S. W. Krause, P. J. Oefner, K. Le-blanc, A. Mackensen, and D. Mougiakakos, CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs, Blood, vol.124, pp.750-760, 2014.

E. C. Rosser and C. Mauri, Regulatory B cells: origin, phenotype, and function, Immunity, vol.42, pp.607-612

P. A. Blair, L. Y. Norena, F. Flores-borja, D. J. Rawlings, D. A. Isenberg et al., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients, Immunity, vol.32, pp.129-140, 2010.

Y. Iwata, T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba et al.,

M. Bernstein, S. H. Magro, C. M. Williams, A. D. Hall, R. P. St-clair et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, pp.530-541, 2011.

M. Matsumoto, A. Baba, T. Yokota, H. Nishikawa, Y. Ohkawa et al., Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation, Immunity, vol.41, pp.1040-1051, 2014.

S. Lindner, K. Dahlke, K. Sontheimer, M. Hagn, C. Kaltenmeier et al., Interleukin 21-induced granzyme Bexpressing B cells infiltrate tumors and regulate T cells, Cancer Res, vol.73, pp.2468-2479, 2013.

M. Hagn, S. E. Blackwell, T. Beyer, V. Ebel, D. Fabricius et al., B-CLL cells acquire APC-and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21, Int Immunol, vol.26, pp.383-395, 2014.

A. Nouel, P. Pochard, Q. Simon, I. Segalen, Y. Le-meur et al., BCells induce regulatory T cells through TGF-beta/IDO production in A CTLA-4 dependent manner, J Autoimmun, vol.59, pp.53-60, 2015.

S. Drennan, A. D'avola, Y. Gao, C. Weigel, E. Chrysostomou et al., IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus, Leukemia, vol.11, 2016.

M. Hallek, B. D. Cheson, D. Catovsky, F. Caligaris-cappio, G. Dighiero et al., Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, Blood, vol.111, pp.5446-5456, 2008.

L. Roy, C. Deglesne, P. A. Chevallier, N. Beitar, T. Eclache et al., The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia, Blood, vol.120, pp.356-365, 2015.

D. J. Dilillo, J. B. Weinberg, A. Yoshizaki, M. Horikawa, J. M. Bryant et al., Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function, vol.27, pp.170-182, 2013.

D. O. Griffin, N. E. Holodick, and T. L. Rothstein, Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70, J Exp Med, vol.208, pp.67-80, 2011.

V. V. Parekh, D. V. Prasad, P. P. Banerjee, B. N. Joshi, A. Kumar et al., B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1, J Immunol, vol.170, pp.5897-5911, 2003.

J. Noh, W. S. Choi, G. Noh, and J. H. Lee, Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg), vol.10, pp.247-249, 2010.

Z. Vadasz, R. Peri, N. Eiza, G. Slobodin, A. Balbir-gurman et al., The Expansion of CD25(high)IL-10(high)FoxP3(high) B Regulatory Cells Is in Association with SLE Disease Activity, J Immunol Res, p.254245, 2015.

D. M. Hossain, A. K. Panda, A. Manna, S. Mohanty, P. Bhattacharjee et al.,

T. Saha, S. Chakraborty, R. K. Kar, T. Das, S. Chatterjee et al., FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells, Immunity, vol.39, pp.1057-1069, 2013.

S. Lemoine, A. Morva, P. Youinou, J. , and C. , Human T cells induce their own regulation through activation of B cells, J Autoimmun, vol.36, pp.228-238, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00771265

A. Cherukuri, D. M. Rothstein, B. Clark, C. R. Carter, A. Davison et al., Immunologic human renal allograft injury associates with an altered IL-10/TNF-alpha expression ratio in regulatory B cells, J Am Soc Nephrol, vol.25, pp.1575-1585, 2014.

M. Larsen, L. Arnaud, M. Hie, C. Parizot, K. Dorgham et al., Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets, Eur J Immunol, vol.41, pp.2596-2605, 2011.

N. Chiorazzi, K. R. Rai, and M. Ferrarini, Chronic lymphocytic leukemia, N Engl J Med, vol.352, pp.804-815, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01375537

A. Wiestner, A. Rosenwald, T. S. Barry, G. Wright, R. E. Davis et al., ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile, Blood, vol.101, pp.4944-4951, 2003.

F. Morabito, G. Cutrona, M. Gentile, S. Fabris, S. Matis et al., Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study, Br J Haematol, vol.168, pp.455-459, 2015.

M. T. Zilber, S. Gregory, R. Mallone, S. Deaglio, F. Malavasi et al., CD38 expressed on human monocytes: a coaccessory molecule in the superantigeninduced proliferation, Proc Natl Acad Sci U S A, vol.97, pp.2840-2845, 2000.

T. J. Hamblin, J. A. Orchard, A. Gardiner, D. G. Oscier, Z. Davis et al., Immunoglobulin V genes and CD38 expression in CLL, Blood, vol.95, pp.2455-2457, 2000.

T. J. Hamblin, J. A. Orchard, R. E. Ibbotson, Z. Davis, P. W. Thomas et al., CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease, Blood, vol.99, pp.1023-1029, 2002.

A. Krober, T. Seiler, A. Benner, L. Bullinger, E. Bruckle et al., V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia, Blood, vol.100, pp.1410-1416, 2002.

H. Dohner, S. Stilgenbauer, A. Benner, E. Leupolt, A. Krober et al., Genomic aberrations and survival in chronic lymphocytic leukemia, N Engl J Med, vol.343, pp.1910-1916, 2000.

D. Rossi, S. Rasi, V. Spina, A. Bruscaggin, S. Monti et al., Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia, Blood, vol.121, pp.1403-1412, 2013.

D. Rossi, V. Spina, R. Bomben, S. Rasi, M. Dal-bo et al., Association between molecular lesions and specific Bcell receptor subsets in chronic lymphocytic leukemia, Blood, vol.121, pp.4902-4905, 2013.

D. A. Landau, E. Tausch, A. N. Taylor-weiner, C. Stewart, J. G. Reiter et al., Mutations driving CLL and their evolution in progression and relapse, Nature, vol.526, pp.525-530, 2015.

M. D. Bo, M. I. Del-principe, F. Pozzo, D. Ragusa, P. Bulian et al., NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximabbased induction and consolidation treatment, Ann Hematol, vol.93, pp.1765-1774, 2014.

R. Guieze, P. Robbe, R. Clifford, S. De-guibert, B. Pereira et al., Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL, Blood, vol.126, issue.18, pp.2110-2117, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01263113

M. Hallek, L. Wanders, M. Ostwald, R. Busch, R. Senekowitsch et al., Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma, Leuk Lymphoma, vol.22, pp.439-447, 1996.

M. Montillo, T. Hamblin, M. Hallek, E. Montserrat, and E. Morra, Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies, Haematologica, vol.90, pp.391-399, 2005.

M. J. Keating, Chronic lymphocytic leukemia in the next decade: where do we go from here?, Semin Hematol, vol.35, pp.27-33, 1998.

S. Molica, Progression and survival studies in early chronic lymphocytic leukemia, Blood, vol.78, pp.895-899, 1991.

C. Pepper, A. Majid, T. T. Lin, S. Hewamana, G. Pratt et al., Defining the prognosis of early stage chronic lymphocytic leukaemia patients, Br J Haematol, vol.156, pp.499-507, 2012.

B. Eichhorst, T. Robak, E. Montserrat, P. Ghia, P. Hillmen et al., Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, pp.78-84, 2015.

J. A. Woyach, J. , and A. J. , Targeted therapies in CLL: mechanisms of resistance and strategies for management, Blood, vol.126, pp.471-477, 2015.

J. C. Byrd, R. R. Furman, S. E. Coutre, I. W. Flinn, J. A. Burger et al., Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia, N Engl J Med, vol.369, pp.32-42, 2013.

J. R. Brown, J. C. Barrientos, P. M. Barr, I. W. Flinn, J. A. Burger et al., The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia, Blood, vol.125, pp.2915-2922, 2015.

J. R. Brown, S. O'brien, C. D. Kingsley, H. Eradat, J. M. Pagel et al., Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial, Blood, vol.125, pp.2779-2785, 2015.

S. M. Jaglowski, J. A. Jones, V. Nagar, J. M. Flynn, L. A. Andritsos et al., Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study, vol.126, pp.842-850, 2015.

M. A. Schwarzbich, F. Mcclanahan, and J. Gribben, Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment Strategies, Oncology, vol.30, p.540, 2016.

A. Mato and D. L. Porter, A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs, Blood, vol.126, pp.478-485, 2015.

N. Baumgarth, The double life of a B-1 cell: self-reactivity selects for protective effector functions, Nat Rev Immunol, vol.11, pp.34-46, 2011.

H. P. Savage and N. Baumgarth, Characteristics of natural antibody-secreting cells, Ann N Y Acad Sci, vol.1362, pp.132-142, 2015.

M. Aziz, N. E. Holodick, T. L. Rothstein, W. , and P. , The role of B-1 cells in inflammation, Immunol Res, vol.63, pp.153-166, 2015.

D. O. Griffin, N. E. Holodick, and T. L. Rothstein, Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70, J Exp Med, vol.208, pp.67-80, 2011.

K. Covens, B. Verbinnen, N. Geukens, I. Meyts, F. Schuit et al., Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype, Blood, vol.121, pp.5176-5183, 2013.

Y. Kikushige, F. Ishikawa, T. Miyamoto, T. Shima, S. Urata et al., Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia, Cancer Cell, vol.20, pp.246-259, 2011.

A. A. Alizadeh, M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, vol.403, pp.503-511, 2000.

A. Rosenwald, A. A. Alizadeh, G. Widhopf, R. Simon, R. E. Davis et al., Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia, J Exp Med, vol.194, pp.1639-1647, 2001.

S. Casola, K. L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot et al., B cell receptor signal strength determines B cell fate, Nat Immunol, vol.5, pp.317-327, 2004.

E. Diamant, Z. Keren, and D. Melamed, CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing, Blood, vol.105, pp.3247-3254, 2005.

W. N. Khan, F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson et al., Defective B cell development and function in Btk-deficient mice, Immunity, vol.3, pp.283-299, 1995.

P. A. Deglesne, N. Chevallier, R. Letestu, F. Baran-marszak, T. Beitar et al., Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression, Cancer Res, vol.66, pp.7158-7166, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02060842

B. T. Messmer, D. Messmer, S. L. Allen, J. E. Kolitz, P. Kudalkar et al., In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells, J Clin Invest, vol.115, pp.755-764, 2005.

J. A. Burger, M. P. Quiroga, E. Hartmann, A. Burkle, W. G. Wierda et al., High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation, Blood, vol.113, pp.3050-3058, 2009.

M. Nishio, T. Endo, N. Tsukada, J. Ohata, S. Kitada et al., Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha, Blood, vol.106, pp.1012-1020, 2005.

E. Ferretti, M. Bertolotto, S. Deaglio, C. Tripodo, D. Ribatti et al., A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment, Leukemia, vol.25, pp.1268-1277, 2011.

N. Tsukada, J. A. Burger, N. J. Zvaifler, and T. J. Kipps, Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia, Blood, vol.99, pp.1030-1037, 2002.

K. Okkenhaug and J. A. Burger, Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL), Curr Top Microbiol Immunol, vol.393, pp.123-142, 2016.

S. Deaglio, T. Vaisitti, L. Bergui, L. Bonello, A. L. Horenstein et al., CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival, Blood, vol.105, pp.3042-3050, 2005.

I. M. Ghobrial, N. D. Bone, M. J. Stenson, A. Novak, K. E. Hedin et al., Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in Bcell chronic lymphocytic leukemia/ small lymphocytic lymphoma, Mayo Clin Proc, vol.79, pp.318-325, 2004.

A. Burkle, M. Niedermeier, A. Schmitt-graff, W. G. Wierda, M. J. Keating et al., Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia, Blood, vol.110, pp.3316-3325, 2007.

K. Heinig, M. Gatjen, M. Grau, V. Stache, I. Anagnostopoulos et al., Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation, Cancer Discov, vol.4, pp.1448-1465, 2014.

A. Vlad, P. A. Deglesne, R. Letestu, S. Saint-georges, N. Chevallier et al., Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease, Cancer Res, vol.69, pp.6387-6395, 2009.

S. Saint-georges, M. Quettier, M. Bouyaba, S. Le-coquil, V. Lauriente et al., Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia, Oncotarget, vol.52, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02060827

C. Mauri and P. A. Blair, Regulatory B cells in autoimmunity: developments and controversies, Nat Rev Rheumatol, vol.6, pp.636-643, 2010.

S. D. Wolf, B. N. Dittel, F. Hardardottir, C. A. Janeway, and . Jr, Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice, J Exp Med, vol.184, pp.2271-2278, 1996.

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nat Immunol, vol.3, pp.944-950, 2002.

C. Mauri, D. Gray, N. Mushtaq, and M. Londei, Prevention of arthritis by interleukin 10-producing B cells, J Exp Med, vol.197, pp.489-501, 2003.

A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, Immunity, vol.16, pp.219-230, 2002.

N. A. Carter, R. Vasconcellos, E. C. Rosser, C. Tulone, A. Munoz-suano et al., Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells, J Immunol, vol.186, pp.5569-5579, 2011.

J. G. Evans, K. A. Chavez-rueda, A. Eddaoudi, A. Meyer-bahlburg, D. J. Rawlings et al., Novel suppressive function of transitional 2 B cells in experimental arthritis, J Immunol, vol.178, pp.7868-7878, 2007.

K. Yanaba, J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto et al., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, pp.639-650, 2008.

K. Yanaba, J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, vol.182, pp.7459-7472, 2009.

T. Matsushita, K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder, Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression, J Clin Invest, vol.118, pp.3420-3430, 2008.

S. Xiao, N. Najafian, J. Reddy, M. Albin, C. Zhu et al., Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function, J Exp Med, vol.204, pp.1691-1702, 2007.

Q. Ding, M. Yeung, G. Camirand, Q. Zeng, H. Akiba et al., Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice, J Clin Invest, vol.121, pp.3645-3656, 2011.

C. Mauri and M. Menon, The expanding family of regulatory B cells, Int Immunol, vol.27, pp.479-486, 2015.

L. Qian, C. Qian, Y. Chen, Y. Bai, Y. Bao et al., Regulatory dendritic cells program B cells to differentiate into CD19hiFcgammaIIbhi regulatory B cells through IFN-beta and CD40L, Blood, vol.120, pp.581-591, 2012.

A. R. Khan, E. Hams, A. Floudas, T. Sparwasser, C. T. Weaver et al., PDL1hi B cells are critical regulators of humoral immunity, Nat Commun, vol.6, p.5997, 2015.

M. Matsumoto, A. Baba, T. Yokota, H. Nishikawa, Y. Ohkawa et al., Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation, Immunity, vol.41, pp.1040-1051, 2014.

F. Flores-borja, A. Bosma, D. Ng, V. Reddy, M. R. Ehrenstein et al., CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation, Sci Transl Med, vol.5, pp.173-123, 2013.

Y. Iwata, T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, pp.530-541, 2011.

D. O. Griffin and T. L. Rothstein, Human "orchestrator" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity, Mol Med, vol.18, pp.1003-1008, 2012.

W. Lin, D. Cerny, E. Chua, K. Duan, J. T. Yi et al., Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate, J Allergy Clin Immunol, vol.193, pp.1204-1212, 2013.

A. Das, G. Ellis, C. Pallant, A. R. Lopes, P. Khanna et al., IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection, J Immunol, vol.189, pp.3925-3935

T. Tretter, R. K. Venigalla, V. Eckstein, R. Saffrich, S. Sertel et al., Induction of CD4+ T-cell anergy and apoptosis by activated human B cells, Blood, vol.112, pp.4555-4564, 2008.

A. Yoshizaki, T. Miyagaki, D. J. Dilillo, T. Matsushita, M. Horikawa et al., Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions, Nature, vol.491, pp.264-268, 2012.

E. Mizoguchi, A. Mizoguchi, F. I. Preffer, and A. K. Bhan, Regulatory role of mature B cells in a murine model of inflammatory bowel disease, Int Immunol, vol.12, pp.597-605, 2000.

M. Matsumoto, Y. Fujii, A. Baba, M. Hikida, T. Kurosaki et al., The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production, Immunity, vol.34, pp.703-714, 2011.

G. Jin, Y. Hamaguchi, T. Matsushita, M. Hasegawa, D. Le-huu et al., B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells, J Allergy Clin Immunol, vol.131, pp.1674-1682, 2013.

J. D. Bouaziz, S. Calbo, M. Maho-vaillant, A. Saussine, M. Bagot et al., IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro, Eur J Immunol, vol.40, pp.2686-2691, 2010.

S. Ziegler, K. Gartner, U. Scheuermann, T. Zoeller, J. Hantzschmann et al., Ca(2+) -related signaling events influence TLR9-induced IL-10 secretion in human B cells, Eur J Immunol, vol.44, pp.1285-1298, 2014.

H. Niiro and E. A. Clark, Regulation of B-cell fate by antigen-receptor signals, Nat Rev Immunol, vol.2, pp.945-956, 2002.

J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott et al., Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice, J Immunol, vol.167, pp.1081-1089, 2001.

V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. Calderon-gomez et al., TLR-activated B cells suppress T cell-mediated autoimmunity, J Immunol, vol.180, pp.4763-4773, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00324528

J. M. Isaza-correa, Z. Liang, . Van-den, A. Berg, A. Diepstra et al., Toll-like receptors in the pathogenesis of human B cell malignancies, J Hematol Oncol, vol.7, p.57, 2014.

C. Kaltenmeier, A. Gawanbacht, T. Beyer, S. Lindner, T. Trzaska et al., CD4+ T cellderived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme Bexpressing regulatory B cells in HIV patients, J Immunol, vol.194, pp.3768-3777, 2015.

S. Kuchen, R. Robbins, G. P. Sims, C. Sheng, T. M. Phillips et al., Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration, J Immunol, vol.179, pp.5886-5896, 2007.

D. Yehudai, A. Snir, R. Peri, K. Halasz, T. Haj et al., B cellactivating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells, Scand J Immunol, vol.76, pp.371-377, 2012.

K. W. Moore, R. De-waal-malefyt, R. L. Coffman, and A. Garra, Interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol, vol.19, pp.683-765, 2001.

B. Stanic, W. Van-de-veen, O. F. Wirz, B. Ruckert, H. Morita et al., IL-10-overexpressing B cells regulate innate and adaptive immune responses, J Allergy Clin Immunol, vol.135, pp.771-780, 2015.

S. Mocellin, F. M. Marincola, Y. , and H. A. , Interleukin-10 and the immune response against cancer: a counterpoint, J Leukoc Biol, vol.78, pp.1043-1051, 2005.

C. Woiciechowsky, K. Asadullah, D. Nestler, B. Eberhardt, C. Platzer et al., Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury, Nat Med, vol.4, pp.808-813, 1998.

A. Oberholzer, C. Oberholzer, and L. L. Moldawer, Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug, Crit Care Med, vol.30, pp.58-63, 2002.

A. Yoshimura, Y. Wakabayashi, and T. Mori, Cellular and molecular basis for the regulation of inflammation by TGF-beta, J Biochem, vol.147, pp.781-792, 2010.

M. Hagn and B. Jahrsdorfer, Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway, Oncoimmunology, vol.1, pp.1368-1375, 2012.

B. Jahrsdorfer, S. E. Blackwell, J. E. Wooldridge, J. Huang, M. W. Andreski et al., B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation, Blood, vol.108, pp.2712-2719, 2006.

P. Shen, T. Roch, V. Lampropoulou, R. A. O'connor, U. Stervbo et al., IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.507, pp.366-370, 2014.

R. X. Wang, C. R. Yu, I. M. Dambuza, R. M. Mahdi, M. B. Dolinska et al., Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Nat Med, vol.20, pp.633-641, 2014.

C. Mauri and K. Nistala, Interleukin-35 takes the 'B' line, Nat Med, vol.20, pp.580-581, 2015.

G. Fonseca-camarillo, J. Furuzawa-carballeda, and J. K. Yamamoto-furusho, Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease, Cytokine, vol.75, pp.389-402, 2015.

T. Sun, D. Zhang, Y. Yang, X. Zhang, C. Lv et al., Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia, Br J Haematol, vol.169, pp.278-285, 2015.

J. Noh, G. Noh, H. S. Kim, A. R. Kim, and W. S. Choi, Allergen-specific responses of CD19(+)CD5(+)Foxp3(+) regulatory B cells (Bregs) and CD4(+)Foxp3(+) regulatory T cell (Tregs) in immune tolerance of cow milk allergy of late eczematous reactions, Cell Immunol, vol.274, pp.109-114, 2012.

A. Curti, S. Trabanelli, V. Salvestrini, M. Baccarani, and R. M. Lemoli, The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology, Blood, vol.113, pp.2394-2401, 2009.

A. Nouel, P. Pochard, Q. Simon, I. Segalen, Y. Le-meur et al., BCells induce regulatory T cells through TGF-beta/IDO production in A CTLA-4 dependent manner, J Autoimmun, vol.59, pp.53-60, 2015.

P. Georg and I. Bekeredjian-ding, Plasmacytoid dendritic cells control B cell-derived IL-10 production, Autoimmunity, vol.45, pp.579-583, 2012.

C. S. Zent, W. Ding, M. S. Reinalda, S. M. Schwager, J. D. Hoyer et al., Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis, Leuk Lymphoma, vol.50, pp.1261-1268, 2009.

C. S. Zent, W. Ding, S. M. Schwager, M. S. Reinalda, J. D. Hoyer et al., The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma, Br J Haematol, vol.141, pp.615-621, 2008.

L. Shvidel, T. Tadmor, A. Braester, O. Bairey, N. Rahimi-levene et al., Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases, Ann Hematol, vol.92, pp.661-667, 2013.

A. Quinquenel, C. Al-nawakil, F. Baran-marszak, V. Eclache, R. Letestu et al., Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients, Am J Hematol, vol.90, pp.5-8, 2015.

E. Grignano, A. Mekinian, F. Caux, M. Soussan, F. Cymbalista et al., Systemic granulomatosis and polyarthritis with pitting edema in B-chronic lymphocytic leukemia, Joint Bone Spine, vol.82, pp.294-295, 2015.

L. Huergo-zapico, A. Acebes-huerta, A. P. Gonzalez-rodriguez, J. Contesti, E. Gonzalez-garcia et al., Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease, PLoS One, vol.9, p.108326, 2014.

C. W. Eskelund, L. Nederby, A. H. Thysen, A. Skovbo, A. S. Roug et al., Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia, Leuk Res, vol.35, pp.914-920, 2011.

A. Acebes-huerta, L. Huergo-zapico, A. P. Gonzalez-rodriguez, A. Fernandez-guizan, A. R. Payer et al., Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells, p.265840, 2014.

P. Jain, M. Javdan, F. K. Feger, P. Y. Chiu, C. Sison et al., Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance, Haematologica, vol.97, pp.599-607, 2012.

I. Hus, A. Bojarska-junak, S. Chocholska, W. Tomczak, J. Wos et al., Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity, PLoS One, vol.8, p.78091, 2013.

I. Idler, K. Giannopoulos, T. Zenz, N. Bhattacharya, M. Nothing et al., Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells, Br J Haematol, vol.148, pp.948-950, 2010.

D. P. Lad, S. Varma, N. Varma, M. U. Sachdeva, P. Bose et al., Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias, Leuk Lymphoma, vol.56, pp.2424-2428, 2015.

K. Giannopoulos, M. Schmitt, M. Kowal, P. Wlasiuk, A. Bojarska-junak et al., Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia, Oncol Rep, vol.20, pp.677-682, 2008.

F. Jadidi-niaragh, M. Yousefi, A. Memarian, M. Hojjat-farsangi, J. Khoshnoodi et al., Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression, Cancer Invest, vol.31, pp.121-131, 2013.

A. Biancotto, P. K. Dagur, J. C. Fuchs, A. Wiestner, C. B. Bagwell et al., Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia, Mod Pathol, vol.25, pp.246-259, 2012.

L. Fayad, M. J. Keating, J. M. Reuben, S. O'brien, B. N. Lee et al., Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome, Blood, vol.97, pp.256-263, 2001.

E. Lech-maranda, O. Grzybowska-izydorczyk, K. Wyka, W. Mlynarski, M. Borowiec et al., Serum tumor necrosis factoralpha and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status, Arch Immunol Ther Exp (Warsz), vol.60, pp.477-486, 2012.

M. Rossi, M. Gentile, R. Toscano, A. G. Recchia, S. Bossio et al., Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia, Leuk Lymphoma, vol.55, pp.1394-1396, 2014.

S. S. Alhakeem, V. J. Sindhava, M. K. Mckenna, B. W. Gachuki, J. C. Byrd et al., Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells, Ann N Y Acad Sci, vol.1362, pp.239-249, 2015.

S. Garaud, A. Morva, S. Lemoine, S. Hillion, A. Bordron et al., CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation, J Immunol, vol.186, pp.4835-4844, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00771246

G. Perez-chacon, J. A. Vargas, J. Jorda, M. Morado, S. Rosado et al., CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC, Leuk Res, vol.31, pp.183-193, 2007.

H. Ishida, R. Hastings, J. Kearney, and M. Howard, Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells, J Exp Med, vol.175, pp.1213-1220, 1992.

T. Endo, M. Nishio, T. Enzler, H. B. Cottam, T. Fukuda et al., BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway, Blood, vol.109, pp.703-710, 2007.

D. Saulep-easton, F. B. Vincent, P. S. Quah, A. Wei, S. B. Ting et al., The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells, Leukemia

G. Fabbri and R. Dalla-favera, The molecular pathogenesis of chronic lymphocytic leukaemia, Nat Rev Cancer, vol.16, pp.145-162, 2016.

R. Jitschin, M. Braun, M. Buttner, K. Dettmer-wilde, J. Bricks et al., CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs, Blood, vol.124, pp.750-760, 2014.

E. C. Rosser and C. Mauri, Regulatory B cells: origin, phenotype, and function, Immunity, vol.42, pp.607-612

D. M. Hossain, A. K. Panda, A. Manna, S. Mohanty, P. Bhattacharjee et al., FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells, Immunity, vol.39, pp.1057-1069, 2013.

M. Lotz, E. Ranheim, and T. J. Kipps, Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells, J Exp Med, vol.179, pp.999-1004, 1994.

J. P. Kremer, G. Reisbach, C. Nerl, and P. Dormer, B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta, Br J Haematol, vol.80, pp.480-487, 1992.

R. S. Douglas, R. J. Capocasale, R. J. Lamb, P. C. Nowell, and J. S. Moore, Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta, Blood, vol.89, pp.941-947, 1997.

J. F. Decoteau, P. I. Knaus, H. Yankelev, M. D. Reis, R. Lowsky et al., Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia, Proc Natl Acad Sci U S A, vol.94, pp.5877-5881, 1997.

P. Natarajan, A. Singh, J. T. Mcnamara, E. R. Secor, . Jr et al., Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-beta, and co-localize with CD4+Foxp3+ T cells, Mucosal immunology, vol.5, pp.691-701, 2012.

M. Hagn, V. Ebel, K. Sontheimer, E. Schwesinger, O. Lunov et al., CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B, Eur J Immunol, vol.40, pp.2060-2069, 2010.

D. A. Frank, S. Mahajan, and J. Ritz, B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues, J Clin Invest, vol.100, pp.3140-3148, 1997.

A. Boyd, J. R. Almeida, P. A. Darrah, D. Sauce, R. A. Seder et al., Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection, PLoS One, vol.10, p.128714, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01230981

C. Calissano, R. N. Damle, S. Marsilio, X. J. Yan, S. Yancopoulos et al., Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells, Mol Med, vol.17, pp.1374-1382, 2011.

D. A. Landau, S. L. Carter, P. Stojanov, A. Mckenna, K. Stevenson et al., Evolution and impact of subclonal mutations in chronic lymphocytic leukemia, Cell, vol.152, pp.714-726, 2013.

M. A. Grygorowicz, M. Biernacka, M. Bujko, E. Nowak, G. Rymkiewicz et al., Human regulatory T cells suppress proliferation of B lymphoma cells, Leuk Lymphoma, vol.57, pp.1903-1920, 2016.